Krystal Biotech buy Chardan Capital
Start price
25.07.25
/
50%
€125.75
Target price
25.07.26
€186.52
Performance (%)
2.19%
Price
15.08.25
€128.50
Summary
This prediction is currently active. The BUY prediction by Chardan_Capital shows slight gains of 2.19%. This prediction currently runs until 25.07.26. The prediction end date can be changed by Chardan_Capital at any time. Chardan_Capital has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Krystal Biotech | 7.757% |
| iShares Core DAX® | 0.648% |
| iShares Nasdaq 100 | -0.034% |
| iShares Nikkei 225® | 2.445% |
| iShares S&P 500 | 0.492% |
Comments by Chardan_Capital for this prediction
In the thread Krystal Biotech diskutieren
Krystal Biotech, Inc. (NASDAQ: KRYS) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $219.00 price target on the stock.
Ratings data for KRYS provided by MarketBeat
Stopped prediction by Chardan_Capital for Krystal Biotech
Krystal Biotech
Start price
Target price
Perf. (%)
€116.70
07.05.25
07.05.25
€193.05
07.05.26
07.05.26
10.11%
15.08.25
15.08.25
Krystal Biotech
Start price
Target price
Perf. (%)
€172.25
20.02.25
20.02.25
€208.60
20.02.26
20.02.26
-25.40%
15.08.25
15.08.25
Krystal Biotech
Start price
Target price
Perf. (%)
€151.90
18.12.24
18.12.24
€202.14
18.12.25
18.12.25
-15.40%
15.08.25
15.08.25
Krystal Biotech
Start price
Target price
Perf. (%)
€165.85
12.12.24
12.12.24
€201.99
12.12.25
12.12.25
-22.52%
15.08.25
15.08.25